366P ADAR1-driven MALAT1 RNA editing differences in tumor and tumor microenvironment of treated vs treatment-naïve breast cancer patients

RNA-editing has been associated with therapy resistance and clinical outcomes. While bulk RNA-seq analyses supports this finding, the cell type–specific dynamics in breast cancer (BC) remain poorly defined.

Authors

Institutions

Publication Details

Journal
Immuno-Oncology Technology
Published
2025-12-01
DOI
https://doi.org/10.1016/j.iotech.2025.101566
Primary Topic
RNA regulation and disease
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

366P ADAR1-driven MALAT1 RNA editing differences in tumor and tumor microenvironment of treated vs treatment-naïve breast cancer patients

M. Sjöberg, A. Blanco, R. Armisen, Y.A. Bernal
Immuno-Oncology Technology
RNA regulation and disease
article

366P ADAR1-driven MALAT1 RNA editing differences in tumor and tumor microenvironment of treated vs treatment-naïve breast cancer patients

M. Sjöberg, A. Blanco, R. Armisen, Y.A. Bernal
article en

Abstract

RNA-editing has been associated with therapy resistance and clinical outcomes. While bulk RNA-seq analyses supports this finding, the cell type–specific dynamics in breast cancer (BC) remain poorly defined.

Immuno-Oncology TechnologyVol. 28
Universidad del Desarrollo (CL), Pontificia Universidad Católica de Chile (CL)
Good health and well-being
Openalex Percentile: Top 36%
RNA regulation and disease
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

366P ADAR1-driven MALAT1 RNA editing differences in tumor and tumor microenvironment of treated vs treatment-naïve breast cancer patients — M. Sjöberg, A. Blanco, et al. · Immuno-Oncology Technology (2025) | TGRS Research Map | TGRS